NIH is addressing the serious issue of Tick-borne Diseases
Tick-borne diseases are emerging as a serious public health problem in the United States. Ticks transmit different infectious diseases including Lyme disease, Rocky Mountain spotted fever and babesiosis. According to CDC, there is more than 30,000 cases of Lyme disease reported each year in the U.S. while the actual incidence of Lyme disease is ten times greater. NIH is developing a strategic plan to accelerate research to develop new diagnostics and therapeutics to address the issue. The federal advisory committee known as Tick-borne Disease Working Group has issued its first report to Congress in 2018.
NIH is seeking comments and suggestions from stakeholders throughout the scientific research, advocacy and clinical practice communities and the general public on tick-borne disease research priorities to continue or adopt over the coming years: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-077.html. Please, submit your queries to NIHTBDStrategicPlan@nih.gov.
For technologies related to tickborne diseases, please click the following link: https://www.ott.nih.gov/search/node/tickborne.